Last 12 months
Inside the activity.
0 purchase rows · 143 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 34 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 92 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2018 Filed Mar 1, 2018 22:06 UTC |
Herrema Gregory J.Senior Vice President
|
GrantCommon Stock | 4,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009389 · form4.xml · nonDerivative · entry 1 Herrema Gregory J. · CIK 0001434827 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,377 Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:00 UTC |
HOOGASIAN SETH HSr. VP & Retiring Gen. Counsel
|
Tax withholdingCommon Stock | 2,273 | $210.68 | $478,875.64 |
DisclosureSEC source: 0001127602-18-009383 · form4.xml · nonDerivative · entry 2 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP & Retiring Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,999 Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:00 UTC |
HOOGASIAN SETH HSr. VP & Retiring Gen. Counsel
|
GrantCommon Stock | 6,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009383 · form4.xml · nonDerivative · entry 1 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP & Retiring Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,272 F1 · shares: Shares represent a performance-based restricted stock unit award granted on February 28, 2017. The Company's Compensation Committee determined on February 27, 2018, that the performance criteria related to this award was satisfied. One-third of the shares vested on February 27, 2018, one-third of the shares vest on February 27, 2019, and the remaining one-third vest on February 27, 2020. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:09 UTC |
Durbin Patrick MSenior Vice President
|
GrantStock Option (Right to Buy) · Derivative | 18,300 | $0.00 Strike: $210.68 | $0.00 |
DisclosureSEC source: 0001127602-18-009392 · form4.xml · derivative · entry 5 Durbin Patrick M · CIK 0001656287 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,300 Underlying: Common Stock · 18,300 shares Expires 2025-02-27 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 27, 2019. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:09 UTC |
Durbin Patrick MSenior Vice President
|
Tax withholdingCommon Stock | 678 | $210.68 | $142,841.04 |
DisclosureSEC source: 0001127602-18-009392 · form4.xml · nonDerivative · entry 3 Durbin Patrick M · CIK 0001656287 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,407 Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:09 UTC |
Durbin Patrick MSenior Vice President
|
GrantCommon Stock | 6,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009392 · form4.xml · nonDerivative · entry 2 Durbin Patrick M · CIK 0001656287 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,085 F1 · shares: Shares represent a performance-based restricted stock unit award granted on February 28, 2017. The Company's Compensation Committee determined on February 27, 2018, that the performance criteria related to this award was satisfied. One-third of the shares vested on February 27, 2018, one-third of the shares vest on February 27, 2019, and the remaining one-third vest on February 27, 2020. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:09 UTC |
Durbin Patrick MSenior Vice President
|
GrantCommon Stock | 4,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009392 · form4.xml · nonDerivative · entry 1 Durbin Patrick M · CIK 0001656287 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,185 Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:12 UTC |
Boxer Michael ASr. VP and Gen. Counsel
|
GrantStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $210.68 | $0.00 |
DisclosureSEC source: 0001127602-18-009393 · form4.xml · derivative · entry 2 Boxer Michael A · CIK 0001726596 · Sr. VP and Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2025-02-27 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 27, 2019. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:12 UTC |
Boxer Michael ASr. VP and Gen. Counsel
|
GrantCommon Stock | 1,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009393 · form4.xml · nonDerivative · entry 1 Boxer Michael A · CIK 0001726596 · Sr. VP and Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,520 Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:19 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 85,850 | $0.00 Strike: $210.68 | $0.00 |
DisclosureSEC source: 0001127602-18-009397 · form4.xml · derivative · entry 6 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,850 Underlying: Common Stock · 85,850 shares Expires 2025-02-27 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 27, 2019. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:19 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 5,912 | $210.68 | $1,245,540.16 |
DisclosureSEC source: 0001127602-18-009397 · form4.xml · nonDerivative · entry 3 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,400.53 Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:19 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
GrantCommon Stock | 39,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009397 · form4.xml · nonDerivative · entry 2 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,312.53 F1 · shares: Shares represent a performance-based restricted stock unit award granted on February 28, 2017. The Company's Compensation Committee determined on February 27, 2018, that the performance criteria related to this award was satisfied. One-third of the shares vested on February 27, 2018, one-third of the shares vest on February 27, 2019, and the remaining one-third vest on February 27, 2020. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:19 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
GrantCommon Stock | 19,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009397 · form4.xml · nonDerivative · entry 1 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,412.53 Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:26 UTC |
Parrett William GDirector
|
SaleCommon Stock | 1,000 | $211.43 | $211,430.00 |
DisclosureSEC source: 0001127602-18-008661 · form4.xml · nonDerivative · entry 1 Parrett William G · CIK 0001418280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,660 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.38 to $211.49, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:28 UTC |
Stevenson Mark PExecutive Vice President & COO
|
Tax withholdingCommon Stock | 1,610 | $211.71 | $340,853.10 |
DisclosureSEC source: 0001127602-18-008667 · form4.xml · nonDerivative · entry 1 Stevenson Mark · CIK 0001387890 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,666 Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:29 UTC |
Williamson StephenSr. VP and CFO
|
Tax withholdingCommon Stock | 594 | $211.71 | $125,755.74 |
DisclosureSEC source: 0001127602-18-008669 · form4.xml · nonDerivative · entry 1 Williamson Stephen · CIK 0001648929 · Sr. VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,147 Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:31 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 87 | $211.71 | $18,418.77 |
DisclosureSEC source: 0001127602-18-008673 · form4.xml · nonDerivative · entry 1 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,682 Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:37 UTC |
HOOGASIAN SETH HSr. VP & Retiring Gen. Counsel
|
Tax withholdingCommon Stock | 449 | $211.71 | $95,057.79 |
DisclosureSEC source: 0001127602-18-008685 · form4.xml · nonDerivative · entry 1 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP & Retiring Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,069 Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:38 UTC |
Herrema Gregory J.Senior Vice President
|
Tax withholdingCommon Stock | 1,167 | $211.71 | $247,065.57 |
DisclosureSEC source: 0001127602-18-008691 · form4.xml · nonDerivative · entry 1 Herrema Gregory J. · CIK 0001434827 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,977 Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:40 UTC |
Durbin Patrick MSenior Vice President
|
Tax withholdingCommon Stock | 449 | $211.71 | $95,057.79 |
DisclosureSEC source: 0001127602-18-008695 · form4.xml · nonDerivative · entry 1 Durbin Patrick M · CIK 0001656287 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,785 Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:43 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 4,964 | $211.71 | $1,050,928.44 |
DisclosureSEC source: 0001127602-18-008703 · form4.xml · nonDerivative · entry 2 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,412.53 Read SEC document |
| February 20, 2018 Filed Feb 27, 2018 21:43 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-008703 · form4.xml · nonDerivative · entry 1 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,376.53 Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:18 UTC |
Parrett William GDirector
|
SaleCommon Stock | 1,000 | $209.80 | $209,796.00 |
DisclosureSEC source: 0001127602-18-007186 · form4.xml · nonDerivative · entry 1 Parrett William G · CIK 0001418280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,660 Read SEC document |
| February 07, 2018 Filed Feb 8, 2018 21:18 UTC |
Williamson StephenSr. VP and CFO
|
SaleCommon Stock | 5,000 | $209.26 | $1,046,300.00 |
DisclosureSEC source: 0001127602-18-004600 · form4.xml · nonDerivative · entry 1 Williamson Stephen · CIK 0001648929 · Sr. VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,741 Read SEC document |
| February 07, 2018 Filed Apr 3, 2018 21:11 UTC |
SPERLING SCOTT MDirector
|
GiftCommon Stock | 9,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-016795 · form4.xml · nonDerivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,164 Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 21:22 UTC |
Durbin Patrick MSenior Vice President
|
SaleCommon Stock | 1,010 | $218.53 | $220,715.30 |
DisclosureSEC source: 0001127602-18-004467 · form4.xml · nonDerivative · entry 3 Durbin Patrick M · CIK 0001656287 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,234 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.25 to $218.87, inclusive. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 21:22 UTC |
Durbin Patrick MSenior Vice President
|
SaleCommon Stock | 3,390 | $217.73 | $738,104.70 |
DisclosureSEC source: 0001127602-18-004467 · form4.xml · nonDerivative · entry 2 Durbin Patrick M · CIK 0001656287 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,244 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.16 to $218.15, inclusive. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 21:22 UTC |
Durbin Patrick MSenior Vice President
|
SaleCommon Stock | 1,600 | $216.56 | $346,496.00 |
DisclosureSEC source: 0001127602-18-004467 · form4.xml · nonDerivative · entry 1 Durbin Patrick M · CIK 0001656287 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,634 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.03 to $217.00, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 22:28 UTC |
Herrema Gregory J.Senior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 26,250 | $0.00 Strike: $54.97 | $0.00 |
DisclosureSEC source: 0001127602-18-004353 · form4.xml · derivative · entry 3 Herrema Gregory J. · CIK 0001434827 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,250 shares Expires 2018-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in four equal installments on February 23, 2012, 2013, 2014, and 2015. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 22:28 UTC |
Herrema Gregory J.Senior Vice President
|
SaleCommon Stock | 33,327 | $219.70 | $7,321,941.90 |
DisclosureSEC source: 0001127602-18-004353 · form4.xml · nonDerivative · entry 2 Herrema Gregory J. · CIK 0001434827 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,144 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.50 to $220.37, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 22:28 UTC |
Herrema Gregory J.Senior Vice President
|
Exercise / conversionCommon Stock | 26,250 | $54.97 | $1,442,962.50 |
DisclosureSEC source: 0001127602-18-004353 · form4.xml · nonDerivative · entry 1 Herrema Gregory J. · CIK 0001434827 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 01:45 UTC |
Boxer Michael ASr. VP and Gen. Counsel
|
GrantStock Option (Right to Buy) · Derivative | 7,283 | $0.00 Strike: $192.98 | $0.00 |
DisclosureSEC source: 0001127602-18-000886 · form4.xml · derivative · entry 2 Boxer Michael A · CIK 0001726596 · Sr. VP and Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,283 Underlying: Common Stock · 7,283 shares Expires 2025-01-02 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on January 2, 2019. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 01:45 UTC |
Boxer Michael ASr. VP and Gen. Counsel
|
GrantCommon Stock | 1,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-000886 · form4.xml · nonDerivative · entry 1 Boxer Michael A · CIK 0001726596 · Sr. VP and Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320 Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 00:10 UTC |
WEISLER DION JDirector
|
GrantPhantom Stock Units · Derivative | 164.58 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-000836 · form4.xml · derivative · entry 1 WEISLER DION J · CIK 0001580693 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 783.85 Underlying: Common Stock · 164.58 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of December 31, 2017, at a price of $189.88 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of December 31, 2017, at a price of $189.88 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of December 31, 2017, at a price of $189.88 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 00:06 UTC |
SPERLING SCOTT MDirector
|
GrantPhantom Stock Units · Derivative | 164.58 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-000577 · form4.xml · derivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,674.85 Underlying: Common Stock · 164.58 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of December 31, 2017, at a price of $189.88 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of December 31, 2017, at a price of $189.88 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of December 31, 2017, at a price of $189.88 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 21:28 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $46.56 | $0.00 |
DisclosureSEC source: 0001127602-17-035145 · form4.xml · derivative · entry 7 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2019-11-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 21:28 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
SaleCommon Stock | 16,366 | $192.29 | $3,147,018.14 |
DisclosureSEC source: 0001127602-17-035145 · form4.xml · nonDerivative · entry 5 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,576.53 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.00 to $192.68, inclusive. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 21:28 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
SaleCommon Stock | 26,934 | $191.62 | $5,161,093.08 |
DisclosureSEC source: 0001127602-17-035145 · form4.xml · nonDerivative · entry 4 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,942.53 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.36 to $191.99, inclusive. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 21:28 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
SaleCommon Stock | 5,500 | $191.11 | $1,051,105.00 |
DisclosureSEC source: 0001127602-17-035145 · form4.xml · nonDerivative · entry 3 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,876.53 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.39 to $191.35, inclusive. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 21:28 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
SaleCommon Stock | 1,200 | $189.73 | $227,676.00 |
DisclosureSEC source: 0001127602-17-035145 · form4.xml · nonDerivative · entry 2 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,376.53 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.51 to $189.95, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 21:28 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 50,000 | $46.56 | $2,328,000.00 |
DisclosureSEC source: 0001127602-17-035145 · form4.xml · nonDerivative · entry 1 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,576.53 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 22:39 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $46.56 | $0.00 |
DisclosureSEC source: 0001127602-17-032717 · form4.xml · derivative · entry 6 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2019-11-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 22:39 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
SaleCommon Stock | 400 | $189.28 | $75,712.00 |
DisclosureSEC source: 0001127602-17-032717 · form4.xml · nonDerivative · entry 4 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,576.53 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.21 to $189.45, inclusive. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 22:39 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
SaleCommon Stock | 49,600 | $188.38 | $9,343,648.00 |
DisclosureSEC source: 0001127602-17-032717 · form4.xml · nonDerivative · entry 3 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,976.53 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.03 to $188.92, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 22:39 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 50,000 | $46.56 | $2,328,000.00 |
DisclosureSEC source: 0001127602-17-032717 · form4.xml · nonDerivative · entry 2 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,576.53 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2017 Filed Nov 17, 2017 22:39 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
GiftCommon Stock | 2,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-032717 · form4.xml · nonDerivative · entry 1 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,576.53 Read SEC document |
| September 30, 2017 Filed Oct 2, 2017 21:15 UTC |
WEISLER DION JDirector
|
GrantPhantom Stock Units · Derivative | 165.17 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-028670 · form4.xml · derivative · entry 1 WEISLER DION J · CIK 0001580693 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 619.27 Underlying: Common Stock · 165.17 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of September 30, 2017, at a price of $189.20 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of September 30, 2017, at a price of $189.20 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of September 30, 2017, at a price of $189.20 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 21:05 UTC |
SPERLING SCOTT MDirector
|
GrantPhantom Stock Units · Derivative | 165.17 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-037389 · form4.xml · derivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,510.27 Underlying: Common Stock · 165.17 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of September 30, 2017, at a price of $189.20 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of September 30, 2017, at a price of $189.20 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of September 30, 2017, at a price of $189.20 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 20:27 UTC |
Stevenson Mark PExecutive Vice President & COO
|
GrantStock Option (Right to Buy) · Derivative | 72,700 | $0.00 Strike: $190.59 | $0.00 |
DisclosureSEC source: 0001127602-17-027264 · form4.xml · derivative · entry 1 Stevenson Mark · CIK 0001387890 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,700 Underlying: Common Stock · 72,700 shares Expires 2024-09-07 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on September 7, 2018. Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 20:32 UTC |
Lagarde MichelSenior Vice President
|
GrantStock Option (Right to Buy) · Derivative | 36,500 | $0.00 Strike: $190.59 | $0.00 |
DisclosureSEC source: 0001127602-17-027266 · form4.xml · derivative · entry 2 Lagarde Michel · CIK 0001518973 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,500 Underlying: Common Stock · 36,500 shares Expires 2024-09-07 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on September 7, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.